Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in

Status Terminated

Clinical Trial Summary

This multi-center, prospective, cohort study of 394 subjects that are indicated for standard colonoscopy due to suspected or known colonic disease examines the Given Diagnostic System and the PillCam Colon Capsule in comparison to standard colonoscopy. This study aims a. To evaluate and compare the accuracy of PillCam ™ Colon capsule endoscopy (PCCE) with standard colonoscopy. This study will evaluate the safety of PillCam ™ Colon capsule endoscopy (PCCE)

Clinical Trial Description

The Given® Diagnostic System offers an alternative approach for endoscopic visualization of the colon using capsule endoscopy, a swallowable device which contains imagers, light sources, a power source and a RF transmitter. Advantages of the Given® Diagnostic System include the elimination of the need for conscious sedation, the minimally invasive, painless nature of the exam, and the ability to pursue normal daily activities immediately following the procedure . This multi-center prospective, cohort study will evaluate the performance of PCCE in visualizing the colon. Up to 394 subjects will participate in this study. All subjects to be enrolled will be appropriate candidates for standard colonoscopy based on their clinical indication.

Each subject will undergo PCCE. All generated PCCE RAPID videos will be reviewed by blinded PCCE reading physicians. All readers, experienced in PillCam SB, will have undergone standardized training and passed a qualification test specific to reading and interpreting PCCE videos. Training will be done by reading at least 5 cases to demonstrate proficiency in interpretation of PCCE. PCCE results will be compared with that of a colonoscopy procedure.

Following PCCE procedure, standard colonoscopy will be performed by a colonoscopist blinded to the results of the PCCE. The colonoscopist will be "unblinded" during the standard colonoscopy procedure at three locations on withdrawal of the colonoscope.

Primary Endpoint - Accuracy parameters (sensitivity, specificity, NPV, PPV) of PCCE compared to standard colonoscopy.

• Number, type and severity of adverse events with both PCCE and standard colonoscopy ;

Study Design

Related Conditions & MeSH terms

Colonic Diseases

Clinical Trial Details

NCT number	NCT00440791
Study type	Observational
Source	Medtronic - MITG
Contact
Status	Terminated
Phase
Start date	June 2006
Completion date	July 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02503696` - Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD)	N/A
Completed	`NCT01063231` - Evaluation of PillCam™ Colon 2 in Visualization of the Colon	Phase 3
Terminated	`NCT01119027` - Assessing Effectiveness of Laparoscopic Colorectal Surgical Skills	N/A
Completed	`NCT04074577` - Computer Aided Detection, Tandem Colonoscopy Study	N/A
Not yet recruiting	`NCT04087824` - Deep Learning Algorithm for Recognition of Colonic Segments.	N/A
Completed	`NCT03559543` - Evaluation of Ocoxin®-Viusid® in Metastatic Colorectal Adenocarcinoma	Phase 2
Terminated	`NCT02503631` - Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers
Completed	`NCT01600209` - Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing	N/A
Completed	`NCT01260168` - Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies	N/A
Completed	`NCT00604162` - PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon	Phase 3
Recruiting	`NCT04598880` - Comparison of 1 Liter PEG With Ascorbate and Sodium Picosulfate / Magnesium Citrate for High Quality Colon Cleansing	Phase 4
Completed	`NCT01738425` - A Clinical Phase I Study on GIC-1001 in Healthy Volunteers	Phase 1
Completed	`NCT04080843` - Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients	Phase 2
Terminated	`NCT04644315` - A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors	Phase 2
Completed	`NCT02291445` - Comparing a 182mg Colon-targeted-delivery Peppermint Oil Capsule (Tempocol-ColoPulse®) and a 182mg Enteric-coated Peppermint Oil Capsule (Tempocol®), a Pharmacokinetic Study	Phase 2
Completed	`NCT03037385` - Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors	Phase 1/Phase 2
Completed	`NCT03139942` - Optical Polyp Testing for In Vivo Classification	N/A
Completed	`NCT04263818` - Endoscopist and Endoscope Motions During Colonoscopy	N/A
Recruiting	`NCT05923918` - A Study to Evaluate Safety and Efficacy of PBK_M2101	Phase 3
Completed	`NCT02647866` - Study of a Monoclonal Antibody KHK4083 in Moderate Ulcerative Colitis	Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms